Professor Carol Hodgson is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia. She has held NHMRC funding throughout her career, as PhD scholarship, Early Career Fellowship and currently with an Investigator Grant (2020-2024). She is a Specialist Physiotherapist in Intensive Care at The Alfred Hospital, Melbourne, Australia. She sits on the Executive and Scientific Committee of the International ECMO Network (ECMONet), the Guidelines Leadership Group for National COVID-19 Clinical Evidence Taskforce and is a Council Member of the International Forum of Acute Care Trialists (InFACT). She leads international multicentre trials for the Australian and New Zealand Intensive Care Society Clinical Trials Group. She has over $20M in grant funding and over 190 publications, with expertise in long-term functional recovery after critical illness. She has contributed to international guidelines for the management of patients with acute respiratory distress syndrome, sepsis and COVID-19, including recommendations for the use of mechanical ventilation, high-flow nasal therapy, oxygen, extracorporeal membrane oxygenation, and early rehabilitation.
A review of the evidence